Financial Disclosure

HomeAboutIndustry Resources ▶ Financial Disclosure
2022 Financial Disclosure

ATS Compliance with the Council of Medical Specialty Societies
Code for Interactions with Companies


The American Thoracic Society (ATS) Board of Directors adopted the Council of Medical Specialty Societies Code for Interactions with Companies (CMSS Code) in October 2010.  The CMSS Code Standard 2.2 states:

“Societies will disclose Company support (at a minimum Educational Grants, Corporate Sponsorships, Charitable Contributions, and support of Research Grants), making this information available to their members and the public.”

In compliance with the CMSS Code, the ATS is pleased to disclose annually all financial and in-kind relationships with companies that support or participate in ATS activities, which helps make what we do possible. Below, please find disclosures for the period of January 1, 2022 to December 31, 2022. Companies are listed alphabetically by level.


Educational Grants (Accredited and Independent Non-Accredited Education):

$250,000 to $499,999:

  • Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech

$100,000 to $249,999:

  • Insmed, Inc.; Merck & Co.

$75,000 to $99,999:

  • Janssen Pharmaceuticals

$50,000 to $74,999:

  • AstraZeneca LP; United Therapeutics Corporation

$25,000 to $49,999:

  • Vertex Pharmaceuticals

$10,000 to $25,000:

  • Olympus America Inc.


ATS Research Program Grants:

$50,000 to $99,999:

  • Boehringer Ingelheim Pharmaceuticals, Inc.; CSL Behring; Fisher & Paykel


Exhibit, Industry Programs, and International Conference Advertising Revenue:

$175,000 and above:

  • Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline, Sanofi Genzyme Regeneron;

$100,000 to $174,999:  

  • Amgen Inc./AstraZeneca; AstraZeneca LP; Janssen Pulmonary Hypertension; United Therapeutics; Viatris Inc.; Genentech;

$50,000 to $99,999:

  • Merck & Co.; Olympus America Inc.

$20,000 to $49,999:

  • Medtronic

$10,000 to $19,999:

  • 4DMedical; AMBU; Auris Health; Bayer Healthcare; Biodesix; bioMerieux; Body Vision Medical; FLUIDDA NV; FUJIFILM Healthcare; Grifols USA; Hillrom; Janssen Pharmaceuticals; Karius; MGC Diagnostics; ndd Medical Technologies; Novartis; Philips Respironics; Pulmonx Corporation; ResMed; Takeda; Thirona; THORASYS Thoracic Medical Society Inc.

$1 to $9,999:

  • Acceleron Pharma; ActiGraph; Aerovate Therapeutics; Albus Health ;Allergy & Asthma Network; Alliance of Sleep Apnea Partners (ASAP); Altavant Sciences; Altus Biologics; Associates of Cape Cod, Inc.; AVANOS MEDICAL; BD; Bellerophon Therapeutics, LLC; BetterNight; BiLab; Biovo Technologies; Blade Therapeutics; BMS/Pfizer; Breas Medical; Bristol Myers Squibb; CAIRE Inc.; CareDx, Inc.; Children's Interstitial Lung Disease Foundation; Cipla; Circassia Inc; Clario; ClearMask; CMI Health Inc.; CoapTech; Cognita Labs LLCl Cohero Health, an Aptar Digital Health Company; COOK MEDICAL; COPD Foundation; COSMED USA, Inc.; coVita; Cystic Fibrosis Research, Inc.; Cytovale; EBSCO; ECO MEDICS - ECO PHYSICS, INC.; Electromed, Inc.; Elsevier, Inc.; EMMS; ERBE USA; FDA Center for Tobacco Products; FibroGen, Inc.; Fujifilm Sonosite; GANSHORN Medizin Electronic GmbH; Gossamer Bio; H2H (Heart to Heart) Foundation; Harvard Bioscience; Hayek Medical Devices; Healthup S.A.; Hermansky-Pudlak Syndrome Network, Inc.; Horizon Therapeutics; ibidi USA, Inc.; Inari Medical; Inhibrx, Inc.; Itamar Medical; JAMA Network; KoKo, LLC; La Jolla Pharmaceuticals; Landon Pediatric Foundation; Liquidia; LivaNova PLC; Lung Transplant Foundation; Masimo; Maxtec; Med Learning Group; Memorial Healthcare System; Merck & Co. Inc.; Methapharm; MIR - Medical International Research; ModuleMD; Monaghan Medical Corporation; Morgan Scientific, Inc.; MotherToBaby Pregnancy Studies; Natera; National Board of Echocardiography, Inc.; National Heart, Lung, and Blood Institute; National Jewish Health; National Scleroderma Foundation; NeilMed Pharmaceuticals; NIH/NIAID; Noah Medical; Northwell Health; Nuvaira, Inc.; Nuvoair; OncoCyte; Optellum Ltd.; OTU Medical Inc; Owlstone Medical Ltd; patientMpower; PCD Foundation;; Perigon Health 360; Perma Pure LLC; Pinnacle Biologics; Polarean; PracticeLink; Praxis Medical Devices; Pulmonary Fibrosis Foundation; Pulmonary Hypertension Association; PulmOne USA Inc.; PureTech; ResBiotic; Respiree Pte Ltd; Retia Medical; Rho; Rigel Pharmaceuticals Inc.; Rocket Medical; SCIREQ - an emka TECHNOLOGIES company; Scivita Medical Technology Co., Ltd.; Signifier Medical; SOMNOmedics America Inc.; Soundable Health; Spire Health; Stanford Health Care; STEMCELL Technologies Inc.; Surgical Science - Simbionix Simulators; TechnoPulm Ltd.; TFS HealthScience; The LAM Foundation; The Surgical Company Endovision; Thoracent Inc; TSC Alliance; TSI Healthcare; United States Navy Recruiting; US Acute Care Solutions; US Army Northwest Physician Recruiting Station; Veracyte, Inc.; Verathon Medical; VIDA; Vitalograph; Vituity; Weatherby Healthcare; Wolters Kluwer; Zambon SpA; ZEPHYRx


ATS 2022 Corporate Membership Program:


  • Amgen Inc.; AstraZeneca LP; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals; Sanofi Genzyme Regeneron; Vertex Pharmaceuticals


  • Genentech; Gilead Sciences, Inc.; Insmed, Inc.; Novartis Corporation; Theravance Biopharma; United Therapeutics Corporation


  • CSL Behring; Merck & Co.; Three Lakes Foundation; Viatris, Inc.


  • 4DMedical; Aerovate; Altavant Sciences; CareDx; Fisher & Paykel Health Care Originals; Mallinckrodt Pharmaceuticals; Synairgen; Verona Pharma


  • Bellus Health; Bristol-Myers Squibbs; DevPro BioPharma; Gossamer Bio; Inhibrx; Pulmonx; Sentec; Vitalograph; Vivus; Zambon


ATS Journal and Other Non-Conference Advertising:

$200,000 and above:

  • Boehringer Ingelheim Pharmaceuticals

$50,000 to $200,000:

  • AstraZeneca LP; GlaxoSmithKline; Mylan; Johnson & Johnson

$35,000 to $49,999:

  • Insmed, Inc.; Gilead Sciences, Inc.

$15,000 to $34,999:

  • Temple University Health Systems; Brigham & Women's Hospital; Continued; Boston Medical Products; Janssen Pharmaceuticals; RespirTech; Catalent; Hill-Rom

$1 to $14,999:

  • Veracyte; United Therapeutics Corporation; Spark Therapeutics; Caire; Northwestern; University of Washington; National Jewish Health; Bellascura; Nabriva; Cook County Health; NEEF; University Hospitals Geauga Medical Center; Hanson Wade; Beth Israel Medical Center; Society of Critical Care Medicine


ATS Journal Non-Advertising Revenue (Reprints)

$30,000 and above:

  • Ebsco; Springer; Wolters Kluwer/OVID; Reprints Desk; Copyright Clearance Center

$15,000 to $29,999:

  • None

$1 to $15,000:

  • None


In Kind (Non-Monetary) Support (such as loan of equipment used in hands-on learning courses planned and controlled by the ATS):

  • Abbott; Ambu; Avanos; Breas; Broncus; CAE/Blue Phantom; Cook Medical; Edward LifeSciences; ERBE USA, INC.; Fisher & Paykel Healthcare; FUJIFILM/Sonosite; Getinge ECMO; Getinge Ventilators; Hamilton; Hill-Rom a part of Baxter; Intuitive Surgical; LivaNova; Medtronic; Mindray; Monaghan Medical Corporation; Monarch; Morgan Scientific; NDD; Olympus; Philips Respironics; ResMed; Teleflex; Trucorp; Verathon; Vitalograph; Zephyr (now Pulmonx)


All questions about the Society’s interactions with industry should be directed to Michelle Turenne – Chief of Development.